Skip to main content
MorphoSys AG logo

MorphoSys AG — Investor Relations & Filings

Ticker · MOR ISIN · DE000A3H2XW6 LEI · 529900493806K77LRE72 F Manufacturing
Open in API
Filings indexed 1,418 across all filing types
Latest filing 2024-02-19 Declaration of Voting R…
Country DE Germany
Listing F MOR

About MorphoSys AG

https://www.morphosys.com/

MorphoSys AG is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines, primarily for cancer patients. The company specializes in creating therapeutic monoclonal antibodies, utilizing its long-standing expertise and proprietary technology platforms to generate fully human antibodies. Its research and development efforts are concentrated on building a pipeline of novel treatments to address significant unmet medical needs in oncology. In February 2024, Novartis entered into an agreement to acquire MorphoSys, aiming to integrate its antibody technologies and oncology pipeline.

Recent filings

Filing Released Lang Actions
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled 'Voting Rights Announcements' and explicitly states 'Notification of Major Holdings' under German Securities Trading Act (WpHG) regulations. It details changes in the percentage of voting rights held by JPMorgan Chase & Co. and its subsidiaries, crossing specific thresholds (Section 6 shows the new total percentage). This type of filing, reporting changes in significant share ownership, directly corresponds to the Major Shareholding Notification category.
2024-02-19 English
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in share ownership, voting rights percentages, and instrument holdings by a legal entity (Societe Generale SA) in MorphoSys AG, referencing specific sections of the German Securities Trading Act (WpHG). This directly aligns with the definition of a notification regarding changes in significant share ownership thresholds, which corresponds to the Major Shareholding Notification category (MRQ). Although the header mentions 'Voting Rights Announcements', the content structure is a formal notification of holding changes, which is best captured by MRQ, or potentially DVA if it were the final results of a vote, but here it is a holding change notification. Given the specific structure detailing 'Notification of Major Holdings' and crossing thresholds, MRQ is the most precise fit over the broader DVA or RNS.
2024-02-19 English
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed sections labeled 'Notification of Major Holdings'. It reports changes in voting rights percentages (e.g., 0.14% direct, 7.15% through instruments) held by Societe Generale SA in MorphoSys AG, referencing specific German securities laws (WpHG sections 33, 34, 38, 40). This content directly corresponds to the definition of reporting changes in significant share ownership thresholds, which aligns best with the 'Major Shareholding Notification' category (MRQ). Although it is a regulatory announcement, MRQ is more specific than the general RNS fallback.
2024-02-19 English
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled 'Voting Rights Announcements' and explicitly references compliance with Article 40, Section 1 of the WpHG (German Securities Trading Act). It details a 'Notification of Major Holdings' by DWS Investment GmbH, showing changes in the percentage of voting rights held in MorphoSys AG, including direct shares and instruments. This content directly corresponds to regulatory filings concerning changes in significant share ownership thresholds. The most appropriate category is Major Shareholding Notification (MRQ).
2024-02-19 English
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled 'Voting Rights Announcements' and explicitly states 'Notification of Major Holdings' under German Securities Trading Act (WpHG) regulations. It details changes in voting rights percentages (Section 6) and ownership structures involving instruments (Section 7.b.2) held by an individual and associated entities. This content directly corresponds to reporting requirements for changes in significant share ownership thresholds, which aligns with the definition for Major Shareholding Notification (MRQ). Although it mentions 'Voting Rights Announcements' in the header, the core content is the detailed disclosure of holding changes, making MRQ more specific than DVA (Declaration of Voting Results) or RNS (General Regulatory Filing).
2024-02-19 English
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in share ownership, voting rights percentages, and instruments held by a legal entity (Morgan Stanley) in MorphoSys AG, referencing German Securities Trading Act (WpHG) articles. This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership thresholds. The code for Major Shareholding Notification is MRQ.
2024-02-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.